WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

4.02.26

Wilson Sonsini Advises View Point Medical on Acquisition by Merit Medical
On April 1, 2026, Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has acquired View Point Medical, Inc. The aggregate transaction consideration, including the assumption of View Point liabilities, is approximately $140 million. Wilson Sonsini Goodrich & Rosati advised View Point on the transaction.
Client Highlights

1.08.26

Wilson Sonsini Advises Ventyx Biosciences on $1.2 Billion Acquisition by Eli Lilly
On January 7, 2026, Eli Lilly and Company announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, Inc., a San Diego-based clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammatory-mediated diseases. Under the terms of the agreement, Lilly will acquire all the outstanding shares of Ventyx in an all-cash transaction, valuing at approximately $1.2 billion. Wilson Sonsini is advising Ventyx on the transaction.
Client Highlights

1.07.26

Wilson Sonsini Advises OneStream on Acquisition by Hg
On January 6, 2026, OneStream, the leading enterprise finance management platform, announced that it has entered into a definitive agreement to be acquired by Hg, a leading investor in software, services, and data businesses. The all-cash transaction values OneStream at approximately $6.4 billion in equity value. Wilson Sonsini Goodrich & Rosati advised OneStream on this transaction in a continuation of its long-standing advisory relationship with the company, including leading OneStream’s Up-C IPO in July 2024.
Client Highlights

12.19.25

Wilson Sonsini Advises Cursor on Acquisition of Graphite
On December 19, 2025, Cursor, the leading AI development platform, announced that it has signed a definitive agreement to acquire Graphite, a start-up that uses AI to review code. The financial terms of the deal were not disclosed. Wilson Sonsini Goodrich & Rosati advised Cursor on the transaction.

The transaction brings together best-in-class tools for creating, reviewing, and merging code in the AI age. Graphite will continue to operate independently, with the same team and product. According to Cursor, in the coming months the two companies will explore connecting their products, for instance with tighter integrations between local development and pull requests and smarter code review that learns from both systems.

The Wilson Sonsini team that advised Cursor on the transaction included:

M&A
Rich Mullen
Ryan Cooper
Hallee Moore
Valerie Lopez
Drew Downing
Client Highlights

12.08.25

Wilson Sonsini Advises Harmonic on $145 Million Acquisition of Video Business Segment by MediaKind
On December 8, 2025, Harmonic, a leader in virtualized broadband and video delivery solutions, announced it has received a binding offer from MediaKind, a leader in cloud-based video streaming technology, to acquire its Video Business segment for approximately $145 million in cash. The transaction, which is expected to close in the first half of 2026, is subject to a French employee works council consultation process and customary closing conditions and regulatory approvals. Wilson Sonsini Goodrich & Rosati is advising Harmonic on the transaction.
Client Highlights

12.03.25

Wilson Sonsini Advises Serent Capital on Recapitalization and Exit from Axiom Medical
On December 3, 2025, Serent Capital, a growth-focused private equity firm, announced the successful recapitalization of Axiom Medical, a leading provider of technology-enabled workplace injury management and employee health solutions. After a seven-year partnership with Serent Capital, Axiom Medical has received a strategic growth investment from NMS Capital to support its next phase of expansion. Wilson Sonsini Goodrich & Rosati advised Serent Capital on the transaction.
  
The Wilson Sonsini team that advised Serent Capital on the transaction included:
 
M&A
Rob Ishii
Catherine Riley Tzipori
David Adler
Elia Perez Villamarin
Yifeng Li
Eric Conner
 
Tax
Jonathan Zhu
Derek Wallace
Han Shen
 
Antitrust and Competition
Ben Labow
Kimberley Biagioli
Julio Albornoz
 
Technology Transactions 
Barath Chari
Morgan Kasenchak
Brittany Von Rueden
Stephanie Stark
 
Employee Benefits and Compensation 
Sriram Krishnamurthy
Matthew Norgard
Madeleine Boshart
Jason Chan
Laura Yun
 
Employment 
Nedim Novakovic
 
Data, Privacy, and Cybersecurity 
Matt Staples
Daniel Chen
Chany Kim
 
Regulatory
Jodi Daniel
Andrea Linna
Nawa Lodin
 
For more information, please see Serent’s news release.
Client Highlights

10.13.25

Wilson Sonsini Advises Fivetran on Merger with dbt Labs
On October 13, 2025, Fivetran, a global leader in automated data movement, announced that it signed a definitive agreement to merge with dbt Labs, a pioneer of modern data transformation, in an all-stock deal. The combined company will be approaching $600 million in annual recurring revenue. The transaction marks significant consolidation in the data tooling market as enterprises race to adapt infrastructure for artificial intelligence applications. Wilson Sonsini Goodrich & Rosati advised Fivetran on the transaction.
Client Highlights

9.30.25

Wilson Sonsini Advises Scientist.com on Acquisition by GHO Capital
On September 16, 2025, Scientist.com, a leading AI-enabled R&D orchestration platform for the life sciences industry, announced that it has entered into a definitive agreement to be acquired by GHO Capital Partners LLP (GHO), a specialist investor in global healthcare. Wilson Sonsini Goodrich & Rosati advised Scientist.com on the transaction.
Client Highlights

9.22.25

Wilson Sonsini Advises Netskope on IPO
On September 17, 2025, Netskope, a leader in modern security and networking for the cloud and AI era, announced the pricing of its initial public offering of 47,800,000 shares of its Class A common stock at a public offering price of $19.00 per share. The shares began trading on the Nasdaq Global Select Market on September 18, 2025, under the ticker symbol “NTSK.” The offering closed on September 19, 2025. Additionally, on September 22, 2025, Netskope announced the full exercise of its over-allotment option of 7,170,000 shares of Class A common stock. Wilson Sonsini Goodrich & Rosati advised Netskope on the transaction.
Client Highlights

9.19.25

Wilson Sonsini Advises Anysphere on Acquisition of Koala
Anysphere, the company behind the artificial intelligence coding application Cursor, acquired Koala, an AI-powered customer relationship management start-up. The acquisition brings Koala’s top engineers to Cursor to help build out a dedicated enterprise-readiness team. Wilson Sonsini Goodrich & Rosati advised Anysphere on the transaction.
Client Highlights

8.07.25

Wilson Sonsini Advises Major Shareholders of HistoSonics on $2.25 Billion Majority Stake Acquisition
On August 7, 2025, HistoSonics, the developer of the Edison® Histotripsy System and a pioneer in non-invasive, focused ultrasound therapies, announced a management-led majority stake acquisition valued at approximately $2.25 billion. The transaction was backed by a syndicate of globally recognized private and public investors, including K5 Global, Bezos Expeditions, Wellington Management, and other new and existing investors. Wilson Sonsini advised HistoSonics’ existing major shareholders in connection with the transaction.
Client Highlights

7.30.25

Wilson Sonsini Advises SixFifty on Acquisition by Leading Human Capital Management Company
SixFifty, a legal technology company that automates employment law compliance for HR and legal teams, recently announced its successful acquisition by a leading human capital management company. Terms of the deal were not disclosed. Wilson Sonsini Goodrich & Rosati advised SixFifty on the transaction.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.